Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Week in Review

Summaries of each week's events in China biotech are provided free to all readers.  A weekly email newsletter providing direct links to these articles is also available - click here for free email newsletter...

Week in Review: Alphamab Oncology Plans $350 Million Hong Kong IPO

Week in Review: Pharmaron, a Beijing CRO, Stages $434 Million Hong Kong IPO

Week in Review: Fosun Pharma Acquires Brain Cancer Immunotherapy in $148 Million Deal

Week in Review: BeiGene's BTK Inhibitor Approved in US and China Approval for PD-1 Expected in Two Months

Week in Review: AstraZeneca Announces $1 Billion Fund for China Life Science Startups

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China